University of Hertfordshire

Drug-eluting balloon: new tool in the box

Research output: Contribution to journalReview articlepeer-review

Standard

Drug-eluting balloon : new tool in the box. / Sharma, Sumeet; Kukreja, Neville; Christopoulos, Christos; Gorog, Diana A.

In: Expert Review of Medical Devices, Vol. 7, No. 3, 05.2010, p. 381-8.

Research output: Contribution to journalReview articlepeer-review

Harvard

Sharma, S, Kukreja, N, Christopoulos, C & Gorog, DA 2010, 'Drug-eluting balloon: new tool in the box', Expert Review of Medical Devices, vol. 7, no. 3, pp. 381-8. https://doi.org/10.1586/erd.10.5

APA

Vancouver

Author

Sharma, Sumeet ; Kukreja, Neville ; Christopoulos, Christos ; Gorog, Diana A. / Drug-eluting balloon : new tool in the box. In: Expert Review of Medical Devices. 2010 ; Vol. 7, No. 3. pp. 381-8.

Bibtex

@article{56b58e81dbf742f6bd6c6c9a1d99f129,
title = "Drug-eluting balloon: new tool in the box",
abstract = "Percutaneous coronary intervention has revolutionized coronary revascularization therapy. It is increasingly becoming an attractive alternative to medical therapy and surgical revascularization in the treatment of coronary artery disease. Restenosis is a major challenge, and has been described as the Achilles heel of the procedure. It is a serious occurrence that can lead not only to recurrent angina and repeat revascularization, but also to acute coronary syndromes. Newer devices and strategies are being continuously sought to try and overcome these hurdles. Drug-eluting balloon technology is one such device that can potentially provide the solutions to these problems. This review focuses on the limitations associated with the use of drug-eluting stents in treating in-stent restenosis, and the concept and the available evidence for the use of drug-eluting balloons, particularly the paclitaxel-eluting balloons, in coronary and peripheral revascularization.",
keywords = "Animals, Anti-Inflammatory Agents, Catheterization, Clinical Trials as Topic, Coronary Restenosis, Drug-Eluting Stents, Humans, Journal Article, Review",
author = "Sumeet Sharma and Neville Kukreja and Christos Christopoulos and Gorog, {Diana A}",
year = "2010",
month = may,
doi = "10.1586/erd.10.5",
language = "English",
volume = "7",
pages = "381--8",
journal = "Expert Review of Medical Devices",
issn = "1743-4440",
publisher = "Taylor & Francis",
number = "3",

}

RIS

TY - JOUR

T1 - Drug-eluting balloon

T2 - new tool in the box

AU - Sharma, Sumeet

AU - Kukreja, Neville

AU - Christopoulos, Christos

AU - Gorog, Diana A

PY - 2010/5

Y1 - 2010/5

N2 - Percutaneous coronary intervention has revolutionized coronary revascularization therapy. It is increasingly becoming an attractive alternative to medical therapy and surgical revascularization in the treatment of coronary artery disease. Restenosis is a major challenge, and has been described as the Achilles heel of the procedure. It is a serious occurrence that can lead not only to recurrent angina and repeat revascularization, but also to acute coronary syndromes. Newer devices and strategies are being continuously sought to try and overcome these hurdles. Drug-eluting balloon technology is one such device that can potentially provide the solutions to these problems. This review focuses on the limitations associated with the use of drug-eluting stents in treating in-stent restenosis, and the concept and the available evidence for the use of drug-eluting balloons, particularly the paclitaxel-eluting balloons, in coronary and peripheral revascularization.

AB - Percutaneous coronary intervention has revolutionized coronary revascularization therapy. It is increasingly becoming an attractive alternative to medical therapy and surgical revascularization in the treatment of coronary artery disease. Restenosis is a major challenge, and has been described as the Achilles heel of the procedure. It is a serious occurrence that can lead not only to recurrent angina and repeat revascularization, but also to acute coronary syndromes. Newer devices and strategies are being continuously sought to try and overcome these hurdles. Drug-eluting balloon technology is one such device that can potentially provide the solutions to these problems. This review focuses on the limitations associated with the use of drug-eluting stents in treating in-stent restenosis, and the concept and the available evidence for the use of drug-eluting balloons, particularly the paclitaxel-eluting balloons, in coronary and peripheral revascularization.

KW - Animals

KW - Anti-Inflammatory Agents

KW - Catheterization

KW - Clinical Trials as Topic

KW - Coronary Restenosis

KW - Drug-Eluting Stents

KW - Humans

KW - Journal Article

KW - Review

U2 - 10.1586/erd.10.5

DO - 10.1586/erd.10.5

M3 - Review article

C2 - 20420559

VL - 7

SP - 381

EP - 388

JO - Expert Review of Medical Devices

JF - Expert Review of Medical Devices

SN - 1743-4440

IS - 3

ER -